Skip to content

13F-HR filed by JGP Global Gestao de Recursos Ltda.

JGP Global Gestao de Recursos Ltda. filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-01-23, with 55 holding rows worth $82,342,000.

Accession
0001536562-19-000001
Filed
2019-01-23
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 55 entries on the cover page, a total value of $82,342,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,342,000 with VALUE read as thousands by filing date, 13F file number 028-16384. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KRAFT HEINZ CO COM500754106Stock550,000$23,672,000thousands by filing dateput
ISHARES INC MSCI BRAZIL ETF464286400MSCI BRAZIL ETF500,000$19,100,000thousands by filing date
GENERAL ELEC CO369604103COM1,600,000$12,112,000thousands by filing date
OI SA-ADR670851500ADR2,827,201$4,524,000thousands by filing date
ISHARES TR464287234MSCI EMG MKT ETF50,000$1,953,000thousands by filing datecall
UnitedHealth Group Inc91324P102COM5,893$1,468,000thousands by filing date
SPDR SERIES TRUST78464A730S&P OILGAS EXP50,000$1,327,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM12,292$1,047,000thousands by filing date
INCYTE CORP COM45337C102Stock14,916$949,000thousands by filing date
SEATTLE GENETICS INC812578102COM16,524$936,000thousands by filing date
ILLUMINA INC452327109COM2,917$875,000thousands by filing date
PAGSEGURO DIGITAL LTDG68707101COM CL A43,000$805,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM7,166$782,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM6,449$628,000thousands by filing date
HUMANA INC COM444859102Stock2,044$586,000thousands by filing date
Bristol-Myers Squibb Company110122108COM10,496$546,000thousands by filing date
Cigna Corporation125523100COM2,850$541,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR3,757$527,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock4,160$480,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM4,983$477,000thousands by filing date
Boston Scientific Corporation101137107COM12,271$434,000thousands by filing date
Abbott Laboratories002824100COM5,781$418,000thousands by filing date
DEXCOM INC COM252131107Stock3,433$411,000thousands by filing date
ISHARES INC MSCI BRAZIL ETF464286400MSCI BRAZIL ETF10,000$382,000thousands by filing dateput
Vertex Pharmaceuticals Incorporated92532F100COM2,245$372,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock5,863$370,000thousands by filing date
Merck & Co.,Inc.58933Y105COM4,716$360,000thousands by filing date
EXELIXIS INC COM30161Q104Stock17,215$339,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock2,208$338,000thousands by filing date
ALLERGAN PLCG0177J108SHS2,466$330,000thousands by filing date
BLUEBIRD BIO INC09609G100COM3,281$325,000thousands by filing date
AbbVie,Inc.00287Y109COM3,454$318,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM13,897$314,000thousands by filing date
Elevance Health, Inc.036752103COM1,177$309,000thousands by filing date
Eli Lilly and Company532457108COM2,631$304,000thousands by filing date
CELGENE CORP151020104COM4,551$292,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM30,287$290,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM4,438$286,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM7,723$279,000thousands by filing date
BIOGEN INC COM09062X103Stock855$257,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS2,480$242,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM5,764$237,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO14,870$235,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM2,997$214,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock548$205,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR2,100$202,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock23,724$191,000thousands by filing date
NATERA INC COM632307104Stock12,238$171,000thousands by filing date
IMMUNOMEDICS INC452907108COM11,855$169,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW11,024$150,000thousands by filing date
EPIZYME INC29428V104COM12,398$76,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR10,213$66,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM19,790$64,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM12,568$50,000thousands by filing date
OI SA-ADR670851401Com28,567$7,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001536562-19-000001this filing2019-01-23acceptance time not in the bulk data set